Home
About
Overview
Sharing Data
ORCID
Help
History (20)
Natural killer cell subsets in allograft rejection and tolerance.
A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial).
Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart disease.
Bilateral Vestibulopathy
Personalized medicine: building the GPS to take us there.
See All 20 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Personalized medicine: building the GPS to take us there.
Personalized medicine: building the GPS to take us there. Clin Pharmacol Ther. 2007 Mar; 81(3):321-2.
View in:
PubMed
subject areas
Drug Therapy
Drug-Related Side Effects and Adverse Reactions
Genotype
Humans
Medicine
National Institutes of Health (U.S.)
Pharmacogenetics
United States
authors with profiles
Mark Ratain